The Society for Cardiovascular Angiography and Interventions promotes excellence in invasive and interventional cardiovascular medicine through education and representation, and the advancement of quality standards to enhance patient care.
The American College of Emergency Physicians promotes the highest quality of emergency care and is the leading advocate for emergency physicians, their patients and the public.
The Society for Vascular Medicine is a professional organization that was founded in 1989 to foster a broad mission. The goals of the Society are to improve the integration of vascular biological advances into medical practice, and to maintain high standards of clinical vascular medicine.
NCVH is an educational nonprofit foundation focused on multidisciplinary accredited conferences to advance the field of cardiovascular care using endovascular technologies, pharmacotherapy treatments, peripheral interventions and amputation prevention techniques.
The CardioVascular Coalition’s mission is to advance patient access to care for peripheral artery disease (PAD).
The Preventive Cardiovascular Nurses Association (PCNA) is the leading nursing organization dedicated to preventing cardiovascular disease through assessing risk, facilitating lifestyle changes, and guiding individuals to achieve treatment goals.
The PERT Consortium intends to guide and influence pulmonary embolism (PE) care and research in institutions across the U.S. and will be the driving force behind increased survival rates and the future of PE treatment.
The Anticoagulation Forum is the largest peer organization of anticoagulant service providers in North America.
The North American Thrombosis Forum (NATF)'s mission and areas of focus are reflected in the programmatic efforts. The multi-disciplinary approach to thrombotic disease enhances education, awareness, advocacy, research, prevention, and diagnosis. The organization was conceptualized to complement existing thrombosis-related organizations and provide a forum for those interested in venous thromboembolism and other thrombotic disorders to focus their efforts. The NATFonline website is seen as a forum to enable the necessary conversation between groups that will enhance thrombosis prevention, diagnosis, and treatment.
Our vision is to improve the lives of the millions of people with cardiovascular disease and diabetes, and to work tirelessly to eliminate these diseases. Every year 19 million people around the world die from cardiovascular and metabolic diseases. This tremendous global burden compels us to develop new therapies that will change the face of these diseases and, ultimately, eliminate them. We focus on finding and developing truly transformational therapies that target underlying disease pathways, important pathways, and novel mechanisms of action. We have a very successful track record demonstrated by the development and recent successful launches of our products for the treatment of patients suffering from thrombosis and type 2 diabetes. And we continue to seek and develop the next generation of transformational cardiovascular and metabolic therapies.
Focusing on the Most Devastating Diseases of Our Lifetime
We want to drive down the rates of cardiovascular and metabolic diseases with our science, innovation, and solutions. We are already transforming the treatment of type 2 diabetes and thrombosis with our products. And while these important products continue to change the way doctors are treating diabetes and thrombosis, we are also focused on finding the next wave of transformational treatments for cardiovascular and metabolic diseases that will prevent, intercept, and cure devastating diseases.